{"url_path":"/sec/lpcn/8-k/2026-05-18/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-18","source_url":"https://www.sec.gov/Archives/edgar/data/1535955/0001493152-26-024097-index.html","accession_number":"0001493152-26-024097","cik":"0001535955","ticker":"LPCN","issuer_name":"Lipocine Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1535955/0001493152-26-024097-index.html","primary_entity_key":"0001535955","primary_entity_name":"Lipocine Inc."},"word_count":46,"has_tables":true,"body_markdown":"**Item\n8.01**\n**Other\nEvents**\n\n \n\nOn\nMay 18, 2026, the Company issued a press release announcing Lipocine to present at A.G.P.’s Annual Virtual\nHealthcare Company Showcase on Wednesday, May 20, 2026. The press release is furnished as Exhibit 99.1 to this report and\nincorporated by reference herein."}